Page 3,812«..1020..3,8113,8123,8133,814..3,8203,830..»

What Is Cell Therapy? | eHow – eHow | How to – Discover …

Posted: Published on August 7th, 2014

mom style food tech home money health crafts More3 Browse Articles & Videos By Category Mark Orwell In the summer of 2003, Mark Orwell began his career as a freelance writer focusing on popular culture, music, and film. He continues to write on a broad array of topics from Miami, Florida. His work has been available in the United States, the Caribbean, and South Africa. The world of medicine continues to grow in leaps and bounds. One of the newest and sometimes controversial procedures is cell therapy. It has been in practice for a while now, but isn't without its growing pains. Like many operations, it may seem radical to people, especially when stem cells are involved. However, the research that has been done shows that cell therapy can be effective in treating a number of ailments. Cell therapy works by introducing new cells into a diseased tissue in order to cure an illness. A number of different cells can be used for various circumstances. Stem cells are cells that have not grown into maturity. When introduced to a tissue, they will grow into healthy cells that match that tissue, thus replacing the ill cells and repairing the tissue. This … Continue reading

Posted in Cell Therapy | Comments Off on What Is Cell Therapy? | eHow – eHow | How to – Discover …

Cell Therapy Lyrics – Goodie Mob – LyricsFreak.com

Posted: Published on August 7th, 2014

When the scene unfolds Young girls thirteen years old Expose themselves to any Tom, Dick, and Hank Got mo' stretch marks than these hoes Hollin they got rank See Sega ain't in this new world order Them experimenting in Atlanta, Georgia United Nations, overseas They trained assassins to do search and seize Ain't knocking or asking Them coming for niggas like me Po' white trash, like they Tricks like her back in slavery Concentration camps lace with gas pipes lines Inferno's outdoors like they had back When Adolf Hitler was living in 1945 Listen to me now, believe me Later on in the future look it up Where they say it? Ain't no more Constitution In the event of a race war Places like operation heartbreak hotel Moments tear until air tight vents seat off despair Them say expect no mercy Foot you should be my least worries got to deal with Where my W-2's, 10-99's Unmarked black helicopters swoop down And try to put missiles in mines Who's that peeking in my window POW nobody now Me and my family moved in our apartment complex A gate with the serial code was put up next The claim that this … Continue reading

Posted in Cell Therapy | Comments Off on Cell Therapy Lyrics – Goodie Mob – LyricsFreak.com

Cell Therapy for Diabetes | California’s Stem Cell Agency

Posted: Published on August 7th, 2014

Year 1 The CIRM Diabetes Disease Team is developing a cell therapy to treat insulin-dependent diabetes. The ultimate goal under CIRM Award DR1-01423 is to file an IND with the FDA to allow first-in-human clinical testing of the cell therapy product. To reach that goal, numerous research and development activities need to be successfully executed in parallel, and the project requires careful planning and agile management. This is particularly critical because the planned product is complex and, as a cutting-edge technology, extends into new regulatory territory. In Year 1 of this Award, virtually all aspects of the project remained on track and the 4-year time line to filing an IND remains the same. The planned product is a combination therapy that is expected to alleviate a diabetics need to perform frequent blood monitoring and insulin injections. It will essentially replace or provide needed support to the endocrine pancreas that is lost or damaged in diabetes. The product consists of a human pancreatic progenitor cell population administered in a durable delivery device. Following administration, the progenitor cells mature into human pancreatic islets including functional insulin-producing glucose-responsive beta cells. Prototypes of the product have been tested in hundreds of rodents, and in … Continue reading

Posted in Cell Therapy | Comments Off on Cell Therapy for Diabetes | California’s Stem Cell Agency

Stanford scientists create remote-controlled nanoscale protein motors

Posted: Published on August 7th, 2014

By Shara Tonn Protein filaments (green and red) glide on the surface of a microscope coverslip, their motion driven by engineered molecular motors. The motors shift gears when illuminated with blue light, causing the motion to slow down. In every cell in your body, tiny protein motors are toiling away to keep you going. Moving muscles, dividing cells, twisting DNA they are the workhorses of biology. But there is still uncertainty about how they function. To help biologists in the quest to know more, a team of Stanford bioengineers has designed a suite of protein motors that can be controlled remotely by light. "Biology is full of these nanoscale machines that can perform complex tasks," said Zev Bryant, an assistant professor of bioengineering and leader of the team. "We want to understand how they can convert chemical energy into mechanical work and perform their specific tasks in cells." Bryant's team, including doctoral student Muneaki Nakamura, designed blueprints for protein motors that would respond to light. Splicing together DNA from different organisms such as pig, slime mold and oat the oat had the light-detecting module the bioengineers created DNA codes for each of their protein motors. The remote-controlled nanomotors are described … Continue reading

Posted in BioEngineering | Comments Off on Stanford scientists create remote-controlled nanoscale protein motors

Bioengineering team builds molecular motors to further the study of cell function

Posted: Published on August 7th, 2014

Aug 06, 2014 by Shara Tonn (Phys.org) In every cell in your body, tiny protein motors are toiling away to keep you going. Moving muscles, dividing cells, twisting DNA they are the workhorses of biology. But there is still uncertainty about how they function. To help biologists in the quest to know more, a team of Stanford bioengineers has designed a suite of protein motors that can be controlled remotely by light. "Biology is full of these nanoscale machines that can perform complex tasks," said Zev Bryant, an assistant professor of bioengineering and leader of the team. "We want to understand how they can convert chemical energy into mechanical work and perform their specific tasks in cells." Bryant's team, including doctoral student Muneaki Nakamura, designed blueprints for protein motors that would respond to light. Splicing together DNA from different organisms such as pig, slime mold and oat the oat had the light-detecting module the bioengineers created DNA codes for each of their protein motors. The remote-controlled nanomotors are described by Nakamura, Bryant and their colleagues in a paper that appeared online Aug. 3 in Nature Nanotechnology.When exposed to light, the new protein motors change direction or speed. "It's pretty fine … Continue reading

Posted in BioEngineering | Comments Off on Bioengineering team builds molecular motors to further the study of cell function

Our view: Support foundations efforts to provide scholarships, more eye-related research

Posted: Published on August 7th, 2014

........................................................................................................................................................................................ Another significant fundraising event in Rio Rancho is fast-approaching, but theres still 10 days to register to participate or donate to support a very worthy cause. The Juliette RP Vision Foundation is sponsoring the sixth annual Vision Walk/Run and Car Show on Saturday, Aug. 16, with a pet-friendly 5K walk/run, kids fun run (8 and under), bake sale and other fun activities for the family. All proceeds go toward the foundation to provide scholarships for visually impaired students and to young research scientists who are conducting retinitis pigmentosa and related retina research. Vision Walk/Run will start in the parking lot at Presbyterian Rust Medical Center, 2400 Unser Blvd., in Rio Rancho. Registration is $25 a person, $20 a person for teams of four or more and $10 a person for those 12 and under. Participants will get a T-shirt on the day of the event. The run will begin at 8 a.m., with the walk set to start at 8:05. There will be awards for the three fastest runners in five age categories: 9-19, 20-29, 30-39, 40-49, and 50 and above. People can register online at JulietteVision.org, or sign up the day of the event, beginning at 7 a.m. … Continue reading

Posted in Retinitis Pigmentosa | Comments Off on Our view: Support foundations efforts to provide scholarships, more eye-related research

How Evidence-Based Medicine in Aesthetic Surgery Journal Helps Doctors Treat Patients Confidently – Video

Posted: Published on August 7th, 2014

How Evidence-Based Medicine in Aesthetic Surgery Journal Helps Doctors Treat Patients Confidently Watch as Dr. Monte Eaves, EBM Editor of the Aesthetic Surgery Journal, describes the importance of evidence-based medicine. Learn how understanding the level... By: ASJOnline … Continue reading

Posted in Aesthetic Surgery | Comments Off on How Evidence-Based Medicine in Aesthetic Surgery Journal Helps Doctors Treat Patients Confidently – Video

Researchers seek 'safety lock' against tumor growth after stem cell transplantation

Posted: Published on August 7th, 2014

PUBLIC RELEASE DATE: 6-Aug-2014 Contact: Robert Miranda cogcomm@aol.com Cell Transplantation Center of Excellence for Aging and Brain Repair Putnam Valley, NY. (Aug. 6, 2014) Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious drawback to the transplantation of iPS-NSCs is the potential for tumor growth, or tumorogenesis, post-transplantation. In an effort to better understand this risk and find ways to prevent it, a team of Japanese researchers has completed a study in which they transplanted a human glioblastoma cell line into the intact spinal columns of laboratory mice that were either immunodeficient or immunocompetent and treated with or without immunosuppresant drugs. Bioluminescent imaging was used to track the transplanted cells as they were manipulated by immunorejection. The researchers found that the withdrawal of immunosuppressant drugs eliminated tumor growth and, in effect, created a 'safety lock' against tumor formation as an adverse outcome of cell transplantation. They also confirmed that withdrawal of immunosuppression led to rejection of tumors formed by transplantation of induced pluripotent stem cell derived neural stem/progenitor cells (iPS-NP/SCs). Although the central nervous system has shown difficulty in … Continue reading

Comments Off on Researchers seek 'safety lock' against tumor growth after stem cell transplantation

GMED Outlook Spooks Investors, CYTX Trials Placed On Hold, INCY Gets FDA Date

Posted: Published on August 7th, 2014

Albany Molecular Research Inc. (AMRI: Quote), which reported better-than expected Q2 results, has also upped its full year contract revenue guidance, sending the stock up by more than 7 percent. The company now expects full year contract revenue to range between $275 million and $283 million, up from its prior outlook of $243 million to $253 million. AMRI closed Tuesday's trading at $20.29, up 7.98%. Cytori Therapeutics (CYTX: Quote) plummeted in after-hours trading Tuesday following the company's decision to halt its cell therapy heart failure trials. According to the company, the multi-center, prospective, randomized, double-blind PMA/IDE safety and feasibility (phase I/II) trials investigating adipose-derived stem and regenerative cells in patients who suffer from a severe form of refractory (untreatable) heart failure due to chronic myocardial ischemia, dubbed ATHENA and ATHENA II, were placed on hold based on a safety review of reported cerebrovascular events. CYTX closed Tuesday's trading at $2.10, down 0.47%. In after-hours, the stock was down 22.38% to $1.63. Globus Medical Inc. (GMED: Quote) plunged 19 percent in extended trading on Tuesday as investors were disappointed with downward revision of the company's full-year revenue outlook. The company now expects full year 2014 net sales to be in the … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on GMED Outlook Spooks Investors, CYTX Trials Placed On Hold, INCY Gets FDA Date

UCLA Scientist Receives CIRM Bridging Fund Award to Treat Blinding Eye Disorder

Posted: Published on August 7th, 2014

Posted Tuesday, August 5 9:25 PM Pictured: Dr. Sophie Deng Dr. Sophie Deng, a prominent clinician scientist at UCLAs Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, has been awarded a Bridging Supplement Award of $699,983 from the California Institute of Regenerative Medicine (CIRM), the states stem-cell agency, recognizing her cutting-edge, innovative research. Deng, noted by CIRM as a leader in the field, is a corneal specialist and associate professor of ophthalmology at UCLA. She was one of only two California investigators to receive CIRM Bridging Fund grants. She was awarded a CIRM Early Translational II grant in 2010, totaling $1.6 million, for her project to regenerate functional human corneal epithelial progenitor cells to treat a blinding corneal disorder called limbal stem-cell deficiency (LSCD). The new Bridge grant acknowledges the success of her project to-date and will provide the basis for new investigational drug applications to the FDA that will combine biology and engineering tools to efficiently expand and regenerate patient-specific limbal stem cells for transplantation to treat blindness through the initiation of human clinical trials. This award recognizes the need to bring this stem cell treatment that is available in Europe to the U.S., and … Continue reading

Posted in Stem Cell Human Trials | Comments Off on UCLA Scientist Receives CIRM Bridging Fund Award to Treat Blinding Eye Disorder

Page 3,812«..1020..3,8113,8123,8133,814..3,8203,830..»